Tag: hematopoietic stem cell transplantation industry size

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Hematopoietic Stem Cell Transplantation Market Size?

There has been significant growth noted in the size of the hematopoietic stem cell transplantation market in the past few years. The market is projected to expand from a value of $4.68 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the historic period include the implementation of early transplantation methods, restricted indications and donor sources, advancements in conditioning protocols, the introduction of allogeneic transplants, and the achievement of regulatory milestones.

The market size of hematopoietic stem cell transplantation is anticipated to experience a significant surge in the coming years, with the prediction to reach $7.7 billion in 2029 through a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this growth in the forecast period include the broadening scope of treatment indications, diversification of donor sources, developments in personalized medicine and genomics, alterations in regulations and guidelines, and market enlargement and accessibility. The forecast period is also characterized by major tendencies such as enhancements in transplantation methods, extension of indications, the rise of cellular therapies, donor diversification, and the implementation of a precision medicine approach.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

Which Demand Drivers Are Strengthening The Hematopoietic Stem Cell Transplantation Market?

The rise in blood cancer prevalence is predicted to fuel the growth of the hematopoietic stem cell transplantation market. Blood cancer encompasses a variety of malignancies that interfere with the production and functioning of blood cells. Leukemia, lymphoma, and myeloma make up the primary forms of blood cancer. Hematopoietic stem cell transplantation is typically applied to address blood cancer, replacing malignant-killed stem cells and bone marrow cells. These new stem cells relocate to the bone marrow to create new blood cells, contributing to the growth of hematopoietic stem cell transplantation market. For example, Blood Cancer UK, a UK-based charity, reported in August 2022 that blood cancer is the sixth most common cancer in the UK, with 41,000 new cases identified annually. It’s estimated that blood cancer will affect 250,000 Britons in 2022, with one in 16 men and one in 22 women likely to be affected at some point. Moreover, blood cancer affects over 500 children under the age of 15 each year, including 400 with pediatric leukemia and 100 with lymphoma. Consequently, the surge in blood cancer prevalence propels the hematopoietic stem cell transplantation market.

What Segmentation Insights Are Provided In The Hematopoietic Stem Cell Transplantation Market Research?

The hematopoietic stem cell transplantationmarket covered in this report is segmented –

1) By Type: Allogeneic; Autologous

2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant

4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation

Which Market Trends Are Expected To Define The Future Of The Hematopoietic Stem Cell Transplantation Market?

The gaining traction of product approvals is one leading trend in the hematopoietic stem cell transplantation market. To maintain a robust stand in the market, main players are turning towards the adoption of product authorizations. For example, in April 2022, Priothera Ltd., a late-stage biotech company based in Ireland, got approval for an investigational new drug (IND) from the US Food and Drug Administration (FDA) to start a Phase IIb/III trial of an allogeneic hematopoietic stem cell transplant (HSCT) using mocravimod in acute myeloid leukemia (AML) patients. Known as KRP203, mocravimod is a synthetic modulator of sphingosine 1-phosphate receptor (S1PR). This unique investigational drug’s safety, tolerability, and efficacy have been assessed in Phase I and Phase II trials for multiple autoimmune diseases.

Which Firms Are Driving Innovation Within The Hematopoietic Stem Cell Transplantation Market?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Hematopoietic Stem Cell Transplantation Market?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp

Browse Through More Reports Similar to the Global Hematopoietic Stem Cell Transplantation Market 2025, By The Business Research Company

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Hematopoietic Stem Cell Transplantation Market?

The hematopoietic stem cell transplantation market has recently seen strong growth. Its value is projected to rise from $4.68 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. The growth achieved historically can be attributed to several factors, including the development of early transplantation techniques, the initial state of limited indications and donor sources, continuous advancements in conditioning regimens, the increasing prevalence of allogeneic transplants, and significant regulatory milestones.

The hematopoietic stem cell transplantation market is anticipated to experience significant expansion in the coming years. This market is projected to reach $7.7 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. The expansion during the forecast period is largely attributed to factors such as expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, as well as market expansion and accessibility. Key trends foreseen in this period encompass advancements in transplant techniques, broader expansion of indications, the emergence of new cellular therapies, further donor diversification, and a precision medicine approach.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

What Are The Top Growth Drivers Impacting The Hematopoietic Stem Cell Transplantation Market Outlook?

The hematopoietic stem cell transplantation market is projected to grow due to the increasing prevalence of blood cancer, which encompasses malignancies that impair blood cell development and function, such as leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation serves as a common treatment, replacing stem and bone marrow cells destroyed by the disease, allowing new cells to migrate to the bone marrow and produce fresh blood cells. This drives demand in the hematopoietic stem cell transplantation market. For instance, data shared by Blood Cancer UK in August 2022 revealed 41,000 new blood cancer cases are identified each year, establishing it as the sixth most prevalent malignancy in the UK. The condition is projected to affect approximately 250,000 people in the UK in 2022, impacting one in 16 men and one in 22 women during their lifetimes. Additionally, more than 500 children under the age of 15 are diagnosed with blood cancer annually, with pediatric leukemia accounting for 400 cases and lymphoma for 100. Thus, the escalating incidence of blood cancer is a primary factor propelling the hematopoietic stem cell transplantation market.

What Are The Major Segment Types Covered In The Hematopoietic Stem Cell Transplantation Market?

The hematopoietic stem cell transplantationmarket covered in this report is segmented –

1) By Type: Allogeneic; Autologous

2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant

4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation

Which Ongoing Trends Are Expected To Shape The Hematopoietic Stem Cell Transplantation Market Outlook?

Product approvals are emerging as a significant trend within the hematopoietic stem cell transplantation market. Major companies operating in this market are increasingly adopting such approvals to solidify their market position. A notable example occurred in April 2022, when Priothera Ltd., an Ireland-based late-clinical stage biotechnology company, secured clearance from the United States Food and Drug Administration (FDA) for an investigational new drug (IND). This approval paved the way for commencing an allogeneic hematopoietic stem cell transplant (HSCT) Phase IIb/III research study using mocravimod in patients with acute myeloid leukemia (AML). Mocravimod, which is also known as KRP203, functions as a synthetic sphingosine 1-phosphate receptor (S1PR) modulator. Its safety, tolerability, and effectiveness for several autoimmune diseases have been previously evaluated through Phase I and Phase II trials.

Which Global Market Leaders Are Shaping The Future Of The Hematopoietic Stem Cell Transplantation Sector?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

What Are The Key Regional Factors Influencing The Hematopoietic Stem Cell Transplantation Market Growth?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hematopoietic Stem Cell Transplantation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp

Browse Through More Reports Similar to the Global Hematopoietic Stem Cell Transplantation Market 2025, By The Business Research Company

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Current and Projected Market Size of the Hematopoietic Stem Cell Transplantation Market Through 2034?#_x000D_

The market for hematopoietic stem cell transplantation has seen significant expansion in the past few years. The size of the market is expected to increase from $4.68 billion in 2024 to $5.1 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. The historic growth can be linked to factors such as the development of early transplantation methods, limitations in indications and sources of donors, advancements in preparative regimens, the introduction of allogeneic transplants, and regulatory achievements._x000D_

_x000D_

The market size of hematopoietic stem cell transplantation is projected to experience a swift expansion in the coming years. The estimated value is set to reach$7.7 billion by 2029″ with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecast period include amplified treatment indications, diversification of donor resources, personalized medicine and genomics, alterations in rules and regulations, market broadening and increased accessibility. The forecast period will witness significant advancements such as enhanced transplantation techniques, exponential expansion of indications, emerging cellular therapies, diversified donors, and the application of precision medicine._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Hematopoietic Stem Cell Transplantation Market?#_x000D_

The growth of the hematopoietic stem cell transplantation market is anticipated to be driven by the rising prevalence of blood cancer. Blood cancers are a set of malignancies that interfere with the production and functioning of blood cells. The primary types of blood cancer are leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation, which involves replacing cancer-killed stem cells and bone marrow cells with new ones, is commonly employed to combat blood cancer. These fresh stem cells can then travel to the bone marrow and commence the production of new blood cells. Therefore, these circumstances contribute to the enhancement of the hematopoietic stem cell transplantation market. For example, Blood Cancer UK, a non-profit organization based in the UK, reported in August 2022 that each year 41,000 blood cancer cases are diagnosed, making blood cancer the sixth most common cancer in the country. Blood cancer impacts one in 16 males and one in 22 females in their lifetime and is predicted to affect about 250,000 people in the UK in 2022. Moreover, over 500 child patients under 15 years old suffer from blood cancer each year, with 400 diagnosed with pediatric leukemia and 100 with lymphoma. Consequently, the escalating blood cancer rate propels the hematopoietic stem cell transplantation market._x000D_

_x000D_

#Which Primary Segments of the Hematopoietic Stem Cell Transplantation Market Are Driving Growth and Industry Transformations?#_x000D_

The hematopoietic stem cell transplantationmarket covered in this report is segmented – _x000D_

_x000D_

1) By Type: Allogeneic; Autologous_x000D_

2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders_x000D_

3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant_x000D_

4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics_x000D_

_x000D_

Subsegments:_x000D_

1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation_x000D_

2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Hematopoietic Stem Cell Transplantation Market?# Market?#_x000D_

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Most Significant Market Trends in the Hematopoietic Stem Cell Transplantation Market?#_x000D_

The growing trend of obtaining product approvals is becoming increasingly prevalent in the hematopoietic stem cell transplantation market. Major enterprises within this market are seeking product approvals as a strategy to maintain their market standing. To illustrate, Priothera Ltd., a late-stage clinical biotech company based in Ireland, secured clearance from the FDA in April 2022 for an investigational new drug (IND) to initiate a Phase IIb/III allogeneic hematopoietic stem cell transplant (HSCT) research study involving patients with acute myeloid leukemia (AML) and utilizing mocravimod, also known as KRP203. This modulator, a synthetic sphingosine 1-phosphate receptor (S1PR), has been the subject of Phase I and Phase II trials to determine its safety, tolerability, and efficacy for numerous autoimmune diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Hematopoietic Stem Cell Transplantation Market?#_x000D_

Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient’s damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient’s body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10445_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the hematopoietic stem cell transplantation market grown over the years?

The market size for hematopoietic stem cell transplantation has seen strong growth in recent years. The market is projected to grow from $4.68 billion in 2024 to $5.12 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The growth experienced in the historical period can be traced back to advancements in transplantation methods, limited indicators and donor sources, improvements in preparation procedures, the advent of allogeneic transplants, and regulatory landmarks.

What Is the forecasted market size and growth rate for the hematopoietic stem cell transplantation market?

A swift escalation is anticipated in the size of the hematopoietic stem cell transplantation market in the subsequent years, as it is projected to reach a worth of “$7.73 billion in 2029 with a compound annual growth rate (CAGR) of 10.9%. This surge in the prediction period can be credited to a multitude of factors such as expansion of treatment indications, diversification of donor sources, the implementation of personalized medicine and genomics, changes in regulatory aspects and guidelines, and widening of market access and availability. The upcoming trends in the forecast period encompass advancements in transplant procedures, extended indications, budding cellular therapies, diversity in donor sources and the precision medicine approach.

Get your hematopoietic stem cell transplantation market report here!

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

What are the major factors driving growth in the hematopoietic stem cell transplantation market?

The surge in instances of blood cancer is anticipated to drive the growth of the hematopoietic stem cell transplantation market. Blood cancers are a category of malignancies that disrupt the genesis and functionality of blood cells which include three primary types: leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation, which replaces malignant-killed stem cells and marrow cells, is a frequent treatment for blood cancer. The new stem cells relocate to the bone marrow and commence the production of new blood cells. Consequently, these elements stimulate the growth of the hematopoietic stem cell transplantation market. For instance, a report from Blood Cancer UK, a UK-based charity in August 2022, noted that blood cancer is identified in 41,000 cases annually – thus making it the sixth most common cancer in the UK. Throughout their lifetime, blood cancer affects one in 16 men and one in 22 women, which will account to around 250,000 people affected in the UK in 2022. Additionally, over 500 children below the age of 15 are impacted by blood cancer each year – 400 suffer from pediatric leukemia and 100 from lymphoma. Because of this rising incidence of blood cancer, the hematopoietic stem cell transplantation market is gaining momentum.

What key areas define the segmentation of the global hematopoietic stem cell transplantation Market?

The hematopoietic stem cell transplantation market covered in this report is segmented –

1) By Type: Allogeneic, Autologous

2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant

4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

What are the top market players propelling the growth of the hematopoietic stem cell transplantation industry?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

What are the key trends shaping the future of the hematopoietic stem cell transplantation market?

A key emerging trend in the hematopoietic stem cell transplantation market involves the gaining popularity of product approvals. To maintain their lead in the market, many leading companies in this area are securing approvals for their products. For example, in April 2022, Priothera Ltd., a late-stage biotech firm based in Ireland, was granted clearance for an investigational new drug (IND) by the United States Food and Drug Administration (FDA). This approval allows the start of a Phase IIb/III study using mocravimod in allogeneic hematopoietic stem cell transplants (HSCT) for patients suffering from acute myeloid leukemia (AML). Also known as KRP203, mocravimod is a synthetic modulator of the sphingosine 1-phosphate receptor (S1PR). Its safety, tolerability, and efficacy have been investigated in Phase I and II trials as a unique experimental treatment for several autoimmune diseases.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10445

What regions are dominating the hematopoietic stem cell transplantation market growth?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Hematopoietic Stem Cell Transplantation Market Through 2034?

The market size for hematopoietic stem cell transplantation has exhibited robust growth over the past few years. It is projected to escalate from $4.68 billion in 2024 to $5.12 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. The substantial growth observed in the historic period can be ascribed to advancements in early transplantation methodologies, limitations in indications and donor sources, progress in conditioning regimes, the advent of allogeneic transplants, and regulatory landmarks.

Anticipated to witness speedy expansion in the forthcoming years, the market size for hematopoietic stem cell transplantation is projected to reach “$7.73 billion by 2029, leapfrogging at a compound annual growth rate (CAGR) of 10.9%. The market’s growth during the forecast period can be credited to a variety of factors, including broadening treatment indications, diversifying donor sources, the rise of personalized medicine and genomics, shifts in regulations and guidelines, and the overall market growth and accessibility. The prediction period is marked by multiple trends such as enhancements in transplant procedures, the broadened scope of indications, the rise of inventive cellular therapies, donor diversification, and a precision medicine approach.

What Major Innovations Are Driving the Accelerated Growth of the hematopoietic stem cell transplantation Market?

The surge in blood cancer instances is anticipated to fuel the hematopoietic stem cell transplantation market’s expansion. Blood cancers, categorized as malignancies that hinder the growth and functionality of blood cells, comprise three key types: leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is typically utilized in treating blood cancer, as it replaces the stem cells and marrow cells wiped out by the cancer with new ones which can go to the marrow and start generating fresh blood cells. This, in turn, stimulates the hematopoietic stem cell transplantation market. For instance, in a report by a UK-based non-profit organization, Blood Cancer UK, in August 2022, they noted that an annual identification of around 41,000 blood cancer cases, ranking it as the sixth most prevalent cancer in the UK. Statistically, it impacts one in 16 men and one in 22 women at some point in their lives, with approximately 250,000 people in the UK predicted to be afflicted by it in 2022. Additionally, blood cancer affects over 500 children under 15 every year, with 400 having pediatric leukemia and 100 having lymphoma. Hence, the accelerating prevalence of blood cancer serves as a key driver for the hematopoietic stem cell transplantation market.

Get Your Free Sample of the Global Hematopoietic Stem Cell Transplantation Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the Hematopoietic Stem Cell Transplantation Market?

Major companies operating in the hematopoietic stem cell transplantation market include:

• Pluristem Therapeutics Inc._x000D_

• Lonza Group AG_x000D_

• Escape Therapeutics Inc._x000D_

• Regen Biopharma Inc._x000D_

• Bluebird Bio Inc._x000D_

Which Current Trends Are Having the Most Impact on the Hematopoietic Stem Cell Transplantation Market?

Get Instant Access to the Global Hematopoietic Stem Cell Transplantation Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

What Are the Strategic Segments Comprising the Hematopoietic Stem Cell Transplantation Market and Their Growth Contributions?

The hematopoietic stem cell transplantation market covered in this report is segmented –

1) By Type: Allogeneic, Autologous

2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant

4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation

Which Regions Are Key Players in the Growth of the Hematopoietic Stem Cell Transplantation Market?

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Elements Shape the Definition of the Hematopoietic Stem Cell Transplantation Market?

Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient’s damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient’s body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.

Browse Through More Similar Reports By The Business Research Company:

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: